0001562180-19-001488.txt : 20190228
0001562180-19-001488.hdr.sgml : 20190228
20190228172509
ACCESSION NUMBER: 0001562180-19-001488
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190226
FILED AS OF DATE: 20190228
DATE AS OF CHANGE: 20190228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Matis Louis
CENTRAL INDEX KEY: 0001650991
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37471
FILM NUMBER: 19645026
MAIL ADDRESS:
STREET 1: LISE-MEITNER-STRASSE 30
STREET 2: C/O PIERIS PHARMACEUTICALS, INC.
CITY: FREISING-WEIHENSTEPHAN
STATE: 2M
ZIP: 85354
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001583648
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 300784346
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-246-8998
MAIL ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Marika Inc.
DATE OF NAME CHANGE: 20130805
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-02-26
false
0001583648
PIERIS PHARMACEUTICALS, INC.
PIRS
0001650991
Matis Louis
C/O PIERIS PHARMACEUTICALS, INC.
255 STATE STREET, 9TH FLOOR
BOSTON
MA
02109
false
true
false
false
Chief Development Officer
Stock Option (Right to Buy)
3.09
2019-02-26
4
A
false
96500.00
0.00
A
2029-02-26
Common Stock
96500.00
96500.00
D
The option vests as to 25% of the option shares on February 26, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.
/s/ Marc D. Mantell, Attorney-in-fact
2019-02-28